UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000044814
Receipt number R000050263
Scientific Title A study of Japanese translation and reliability evaluation of the Primary Lateral Sclerosis Functional Rating Scale (PLSFRS) for Primary Lateral Sclerosis (PLS)
Date of disclosure of the study information 2021/07/10
Last modified on 2024/01/10 09:55:31

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A study of Japanese translation and reliability evaluation of the Primary Lateral Sclerosis Functional Rating Scale (PLSFRS) for Primary Lateral Sclerosis (PLS)

Acronym

PLS validation study

Scientific Title

A study of Japanese translation and reliability evaluation of the Primary Lateral Sclerosis Functional Rating Scale (PLSFRS) for Primary Lateral Sclerosis (PLS)

Scientific Title:Acronym

PLS validation study

Region

Japan


Condition

Condition

Primary Lateral Sclerosis

Classification by specialty

Neurology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

We evaluate by face-to-face examination and telephone listening consistent in addition to the evaluation of reliability by making a Japanese version after translating PLSFRS into Japanese.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

We evaluate consistency of scores between evaluators, intra-rater reliability, face-to-face consultation, and telephone listening for all 12 items of PLSFRS and their total scores.

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

100 years-old >=

Gender

Male and Female

Key inclusion criteria

Upper motor neuron dysfunction of unknown cause are observed in at least two of the three regions of cranial nerves, upper limbs, and lower limbs regardless of the duration of illness, and needle electromyography shows normal or active lower motor neuron lesions. Patients meet all of the following.
1) Japanese is the first language.
2) You can sign the consent form. If you cannot sign due to weakness of the upper limbs, or if you cannot answer due to dysarthria, the signature of their substitute is acceptable.
3) Age at diagnosis is 20 years or older
4) No family history or consanguineous marriage.

Key exclusion criteria

1) If you have cognitive decline or deafness including their substitute.
2) When the researchers decide that he/she cannot express his/her intention accurately.
3) If you do not agree to this study.
4) In cases of death during the course
5) When the researchers judge inappropriate.

Target sample size

13


Research contact person

Name of lead principal investigator

1st name Masaru
Middle name
Last name Yanagihashi

Organization

Toho University Faculty of Medicine

Division name

Department of Neurology

Zip code

143-8541

Address

6-11-1 Omorinishi Ota-ku, Tokyo, Japan

TEL

0337624151

Email

masaru.yanagihashi@med.toho-u.ac.jp


Public contact

Name of contact person

1st name Masaru
Middle name
Last name Yanagihashi

Organization

Toho University Faculty of Medicine

Division name

Department of Neurology

Zip code

143-8541

Address

6-11-1 Omorinishi Ota-ku, Tokyo, Japan

TEL

0337624151

Homepage URL


Email

masaru.yanagihashi@med.toho-u.ac.jp


Sponsor or person

Institute

Toho University Omori Medical Center

Institute

Department

Personal name



Funding Source

Organization

Department of Neurology, Toho University Faculty of Medicine

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor

Department of Neurology, Fukushima Medical University School of Medicine, Fukushima, Japan.
Rehabilitation Center, Jichi Medical University Hospital, Shimotsuke, Japan.
Department of Neurology, Tokyo Metropolitan Neurological Hospital, Tokyo, Japan.
Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Department of Neurology, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan.

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Toho University Omori Medical Center

Address

6-11-1 Omorinishi Ota-ku, Tokyo, Japan

Tel

0337624151

Email

masaru.yanagihashi@med.toho-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 07 Month 10 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

15

Results

The quadratic weighted kappa coefficient on intra-rater and inter-rater about each item are substantial agreement (intra-rater; 0.691-1.000, inter-rater; 0.634-1.000). Moreover, the intraclass correlation coefficient (ICC) was 0.997 (95% CI, 0.992-0.999)

Results date posted

2023 Year 01 Month 09 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

Unexplained upper motor neuron disorders in at least two of the three regions of the brain, upper limbs, and lower limbs regardless of the duration of the disease.
Normal needle electromyography, or no evidence of active lower motor neuron disorders
1) Japanese
2) Able to sign a consent form (if unable to sign due to muscle weakness in the upper extremities, or unable to respond due to dysarthria, writing on behalf of the patient is acceptable)
3) 20 years of age or older.
4) No family history or consanguinity

Participant flow

The evaluation of PLSFRS is performed by the face-to-face examination by the first evaluator at the time of registration and 8 weeks later, followed by the face-to-face examination and the telephone interview by another evaluator 4 weeks after the registration.

Adverse events

No adverse events in evaluation occurred

Outcome measures

1,Language
2,Salivation
3,Swallowing
4,Handwriting
5,Cutting food and handling utensils
6,Dressing and hygiene
7,Turning in bed and adjusting bedclothes
8,Walking
9,Climbing Stairs
R-1 Dyspnea
R-2 Orthopnea
R-3 Respiratory insufficiency

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2021 Year 02 Month 22 Day

Date of IRB

2021 Year 07 Month 07 Day

Anticipated trial start date

2021 Year 07 Month 10 Day

Last follow-up date

2023 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Register patients with PLS who meet the selection criteria among the patients who visited our facility.
For registered patients, we evaluate about twelve items,speech, salivation, swallowing, handwriting, cutting food and handling utensils, dressing and hygiene, turning in bed and adjusting bedclothes, walking, climbing stairs, dyspnea, orthopnea and respiratory insufficiency.
Except for orthopnea and respiratory insufficiency, each is evaluated on a 7-point scale of 0 to 6 points, and orthopnea, respiratory insufficiency are evaluated on a 5-point scale of 0 to 4 points, respectively.


Management information

Registered date

2021 Year 07 Month 09 Day

Last modified on

2024 Year 01 Month 10 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050263


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name